Family Medicine · Augusta, ME
NPI
1568579696
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
12 Shuman Ave Ste 6
Augusta, ME, 04330
Phone (207) 307-0958
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
1,130 services
Medicare patients, 2024
139
Average age 65
Drug cost, 2024
$748K
7,108 prescriptions
Company payments, 2025
$47.23
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael D Dufresne was code 36415 (venipuncture blood collection), 156 times for 91 patients. In total Michael D Dufresne billed 1,130 services in 36 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 156 | 91 | $8.54 | $1,333 |
| 99213 Office E&M - Established | Office | 113 | 48 | $56.87 | $6,426 |
| 99214 Office E&M - Established | Office | 76 | 45 | $80.50 | $6,118 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 53 | 53 | $120.45 | $6,384 |
| 90471 Vaccine Administration | Office | 14 | 14 | $11.02 | $154 |
By year: 2022 $32K for 644 services; 2023 $33K for 669 services; 2024 $27K for 1,130 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 156 | 91 | $8.54 | $1,333 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael D Dufresne prescribed most often to Medicare patients was Oxycodone Hcl, with 491 prescriptions and refills. In total Michael D Dufresne wrote 7,108 Medicare prescriptions that cost $748K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 491 | 492 | 60 | $14K |
| Levothyroxine Sodium Generic | 244 | 591 | 65 | $2,490 |
| Atorvastatin Calcium Generic | 236 | 591 | 64 | $1,644 |
| Pregabalin Generic | 174 | 236 | 39 | $6,661 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 171 | 229 | 53 | $5,806 |
| Lisinopril Generic | 161 | 423 | 45 | $737 |
| Losartan Potassium Generic | 153 | 393 | 42 | $1,260 |
| Rosuvastatin Calcium Generic | 153 | 409 | 43 | $3,300 |
| Omeprazole Generic | 146 | 416 | 51 | $2,311 |
| Gabapentin Generic | 141 | 215 | 27 | $2,093 |
| Diazepam Generic | 133 | 143 | 14 | $54K |
| Cyclobenzaprine Hcl Generic | 131 | 179 | 32 | $624 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 112 | 112 | 26 | $3,319 |
| Lorazepam Generic | 109 | 111 | 17 | $552 |
| Furosemide Generic | 104 | 168 | 21 | $385 |
Brand drugs: 922 claims; generic drugs: 6,132 claims; opioid claims: 847.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael D Dufresne $47.23 ($47.23 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Pharmaceuticals, Inc with $47.23.
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc JNJ | 1 | $47.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.